LICI - Fundamental Analysis: Financial Health & Valuation
Back to ListFundamental Rating: 4.2
| Stock Code | LICI | Market Cap | 4,97,178 Cr. | Current Price | 786 ₹ | High / Low | 980 ₹ |
| Stock P/E | 9.38 | Book Value | 223 ₹ | Dividend Yield | 1.53 % | ROCE | 53.4 % |
| ROE | 46.0 % | Face Value | 10.0 ₹ | DMA 50 | 837 ₹ | DMA 200 | 865 ₹ |
| Chg in FII Hold | 0.07 % | Chg in DII Hold | -0.02 % | PAT Qtr | 12,958 Cr. | PAT Prev Qtr | 10,053 Cr. |
| RSI | 35.6 | MACD | -19.9 | Volume | 11,89,323 | Avg Vol 1Wk | 10,73,486 |
| Low price | 743 ₹ | High price | 980 ₹ | PEG Ratio | 0.07 | Debt to equity | 0.00 |
| 52w Index | 18.2 % | Qtr Profit Var | 17.2 % | EPS | 83.8 ₹ | Industry PE | 76.2 |
📊 Financial Overview
- Revenue & Profitability: PAT rose from 10,053 Cr. to 12,958 Cr. QoQ, showing strong earnings momentum. EPS at 83.8 ₹ is robust.
- Margins & Returns: ROE at 46% and ROCE at 53.4% are exceptionally strong, reflecting superior capital efficiency.
- Debt & Liquidity: Debt-to-equity ratio of 0.00 indicates a debt-free balance sheet, enhancing financial stability.
- Cash Flow: Strong profitability supports healthy cash generation and dividend payouts.
💹 Valuation Metrics
- P/E Ratio: 9.38 vs Industry PE of 76.2 → Significantly undervalued.
- P/B Ratio: ~3.52 (Price 786 ₹ / Book Value 223 ₹) → Reasonable relative to assets.
- PEG Ratio: 0.07 → Attractive, reflecting strong earnings growth at low valuation.
- Intrinsic Value: Current price appears below fair value, offering upside potential.
🏢 Business Model & Competitive Advantage
LIC is India’s largest life insurer with a dominant market share, extensive distribution network, and strong brand trust. Its scale, government backing, and diversified product portfolio provide a formidable moat. Despite competition from private insurers, LIC’s reach and customer loyalty remain unmatched.
📈 Entry Zone & Long-Term Guidance
Technically, RSI at 35.6 and negative MACD suggest near-term weakness. A good entry zone would be 740–760 ₹ (near recent lows). Long-term investors can accumulate given strong fundamentals and undervaluation relative to peers.
✅ Positive
- Debt-free balance sheet.
- Strong ROE (46%) and ROCE (53.4%).
- Undervalued compared to industry PE.
- Dividend yield of 1.53% provides income support.
⚠️ Limitation
- Stock under technical pressure (RSI & MACD weak).
- FII and DII holding changes are marginal (+0.07%, -0.02%).
- High dependence on government policies and regulations.
📉 Company Negative News
- Stock price corrected from 980 ₹ to 786 ₹.
- Short-term technical weakness with RSI below 40.
📈 Company Positive News
- Quarterly PAT surged to 12,958 Cr. from 10,053 Cr.
- EPS at 83.8 ₹ reflects strong profitability.
🏭 Industry
The insurance industry in India is growing rapidly, driven by rising financial awareness, regulatory support, and increasing penetration. LIC’s scale and trust advantage position it strongly, though private players are intensifying competition.
🔎 Conclusion
LIC is fundamentally strong, debt-free, and undervalued relative to peers. Despite short-term technical weakness, its superior return ratios and market dominance make it attractive for long-term investors. Accumulation near 740–760 ₹ is recommended for a strong long-term holding.